Showing 1,512 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Finance & funding

HIV drugs to be uniquely shielded from generic pricing pressure in public payer scheme

Editor's pick
Financial Times
1 March 2013
Access to healthcare

GlaxoSmithKline unit joins patent pool for AIDS drugs

Editor's pick
Reuters
27 February 2013
New & experimental hepatitis C treatment

Regulators Await Gilead's Hep C Candidate

Editor's pick
Seeking Alpha
22 February 2013
Pharmaceutical industry

Gilead Settles Teva HIV Drug Patent Suit to Avoid Trial

Editor's pick
Bloomberg
20 February 2013
New & experimental hepatitis C treatment

Gilead's Sofosbuvir for Hepatitis C Meets Primary Endpoint in Fourth Pivotal Phase 3 Study

Editor's pick
Gilead press release
19 February 2013
Pharmaceutical industry

Uganda: Quality Chemicals to Produce New Aids Drug

Editor's pick
AllAfrica
18 February 2013
Pharmaceutical industry

GSK wins priority status for new HIV drug in US

Editor's pick
Reuters
18 February 2013
Access to healthcare

Have a heart, save my liver!

Editor's pick
HepCoalition.org
14 February 2013
Pharmaceutical industry

EMA: Viracept: Non-renewal of the marketing authorisation in the European Union

Editor's pick
European Medicines Agency
7 February 2013
New & experimental HIV treatments

ViiV announces halt to lersivirine development

Editor's pick
HIVandHepatitis.com
7 February 2013
Pharmaceutical industry

Gilead racks up 18% sales hike as HIV meds keep growing

Editor's pick
FiercePharma
6 February 2013
New & experimental hepatitis C treatment

Idenix to Discontinue Development of Two Hepatitis C Treatments

Editor's pick
Idenix press release
5 February 2013
Pharmaceutical industry

Vertex hepatitis C drug revenues plummet

Editor's pick
Boston Business Journal (blog)
30 January 2013
New & experimental hepatitis C treatment

Phase II all-oral combination studies of simeprevir, TMC647055 and IDX719 for the treatment of hepatitis C to be initiated shortly

Editor's pick
Medivir press release
29 January 2013
New & experimental HIV treatments

Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide, a Novel Low-Dose Prodrug for the Treatment of HIV

Editor's pick
Gilead press release
25 January 2013
Pharmaceutical industry

Gilead petitions FDA over its Stribild AIDS med

Editor's pick
Pharmalot
25 January 2013
Pharmaceutical industry

US finds sharp rise in ‘pay-for-delay’ deals blocking generics

Editor's pick
Intellectual Property Watch
21 January 2013
Pharmaceutical industry

Médecins Sans Frontières addresses study by Massachusetts General Hospital on implications of switching from branded to generic antiretrovirals for HIV

Editor's pick
MSF / EATG
17 January 2013
Finance & funding

Study questions generic HIV drug use

Editor's pick
BBC Health
15 January 2013
Finance & funding

Generics Could Cut Costs of HIV Treatment

Editor's pick
MedPage Today HIV/AIDS
15 January 2013
New & experimental hepatitis C treatment

Achillion Continues To Make Significant Strides In The Fight Against Hepatitis C

Editor's pick
Seeking Alpha
15 January 2013
Bad science & bogus treatments

Nigerian texters to take on the drug counterfeiters

Editor's pick
BBC Health
11 January 2013
Pharmaceutical industry

Glaxo Says No Plan for Viiv Spinoff ‘at the Moment’

Editor's pick
Bloomberg
11 January 2013
New & experimental hepatitis C treatment

Idenix May Drop Delayed Hepatitis C Drug for New Versions

Editor's pick
Businessweek
10 January 2013